Share This Page

Maudes Awards

Support & Insight for the Autumn of Life

Drugs

Leqembi: Pioneering Alzheimer’s Drug Faces Challenge in Europe

July 26, 2024 No Comments

While the initial headlines might seem discouraging, there’s always more to the story. 🌟

How to Choose Between Kisunla vs. Leqembi

July 14, 2024 No Comments

The Newest Alzheimer’s Drugs, Kisunla and Leqembi, are the first to actually slow down Alzheimer’s. How do they compare to each other?

Kisunla Approved by FDA, 2nd Drug to Actually Slow Alzheimer’s

July 5, 2024 No Comments

VIDEO + ARTICLE: Kisunla (generic name: Donanemab) slowed cognitive and functional decline 35%. Once-monthly infusions reduced Alzheimer’s plaque 84%.

Leqembi Launched in China to Fight Alzheimer’s

July 3, 2024 No Comments

China is the third country to launch LEQEMBI for sale, to fight Alzheimer’s, following the United States and Japan.

Unlocking Terazosin’s Potential for Dementia with Lewy Bodies

June 26, 2024 1 Comment

Three FDA-Approved drugs, terazosin, doxazosin, and alfuzosin, have a happy side effect; they boost energy production in brain cells. New studies suggest this slows or prevents Dementia with Lewy Bodies.

Woman caring for her mother with dementia

Getting Dementia Patients to Take Their Meds

June 25, 2024 No Comments

Grandma hates taking her medications. With her dementia, she ends up asking 10 different times why she has to take it! What should I do?

FDA Endorses Donanemab, Revolutionary Alzheimer’s Treatment

June 11, 2024 No Comments

The unanimous 11-0 FDA vote clears an exciting path for this new Alzheimer’s drug.

LEQEMBI® for Alzheimer’s Now in USA, China, Japan, South Korea

June 4, 2024 1 Comment

South Korea joined other countries in approving LEQEMBI® (generic lecanemab) for mild cognitive impairment, mild and early Alzheimer’s. Learn how Leqembi is treating Alzheimer’s around the world.

Seroquel-quetiapine Prescriptions Drop 15% After Dementia Warning

May 22, 2024 3 Comments

“People with dementia living in nursing homes and in the community were prescribed less and we did not detect negative health impacts for these groups.”

Leqembi Injection, an Easier Alzheimer’s Treatment, Awaits FDA Approval

May 16, 2024 No Comments

LEQEMBI® is the newest Alzheimer’s drug. It is administered in hospitals via IV. Biogen applied to the FDA for approval of a home version using an “Autoinjector”. See how it works and learn its advantages.

Teepa Snow with Live Audience of Caregivers

Caring for Vascular Dementia

April 14, 2025

TEEPA SNOW CARE VIDEO: Vascular dementia poses unique challenges to caregivers. Learn how vascular dementia differs from Alzheimer’s. See how to make life better, both for you and the one for whom you care.

Dignity & Dementia: Where to Draw the Line?

April 13, 2025

People with dementia deserve dignity and have rights. Where do we draw the line between encouraging personal choices versus following what caregivers think is best? See Dr. Murray Raskin & Dr. Linda Teri offer experienced tips.

wine glasses, wine, drink, red wine, alcohol, glasses, beverage, elegant, luxury, wine, wine, wine, wine, wine, alcohol, luxury

8 Drinks a Week Mess with Memory & Thinking

April 10, 2025

Heavy drinkers who have eight or more alcoholic drinks per week have increased risk of brain lesions called hyaline arteriolosclerosis, signs of brain injury that are associated with memory and thinking problems, according to a new study.